Actively Recruiting
Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA
Led by University Hospital, Rouen · Updated on 2026-02-06
150
Participants Needed
1
Research Sites
339 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of the REMNANT study is to confirm the clinical value of detecting a new biomarker, ctDNA (circulating tumor DNA), in the follow-up of patients with operated liver cancer. In order to meet this objective, this biomarker will be measured in your blood before and after surgery, at three and six months.
CONDITIONS
Official Title
Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �3e= 18 years
- Hepatocellular carcinoma diagnosed by consensus radiological criteria in cirrhotic patients or histologically if imaging diagnosis is not available
- Patient treated by liver resection surgery or radiofrequency tumor destruction
- Treatment decision confirmed by digestive oncology multidisciplinary team
- Patient has read and understood study information and signed consent
- Patient will be followed up at Charles Nicolle University Hospital in Rouen
You will not qualify if you...
- Presence of other active cancer or blood malignancy
- Contraindication to surgery
- Not affiliated to the social security system
- Pregnant, recently gave birth, or breastfeeding
- Under court protection, guardianship, or curatorship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chu Rouen
Rouen, France, 76031
Actively Recruiting
Research Team
E
Edouard ROUSSEL, MD
CONTACT
J
Julie RONDEAUX
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here